Table 2.

Patients’ peripheral blood indexes before treatment (0 week).

Observation indexes	No. of patients(N = 151)	Percentage(%)
NLR, median(IQR)	2.96(2.13-4.54)
> 2.96	75	49.7
≤ 2.96	76	50.3
PLR, median(IQR)	158.62(115.89-229.23)
> 159	75	49.7
≤ 159	76	50.3
PAR(*10^9), median(IQR)	5.14 (3.98-6.42)
≥ 5.15	75	49.7
< 5.15	76	50.3
Hb(g/L), median(IQR)	129.00(118.00-140.00)
≥ 130	75	49.7
< 130	76	50.3
LDH(U/L), median(IQR)	206.00(181.00-258.00)
> 245	42	27.8
≤ 245	109	72.2
CEA(ng/ml), median(IQR)	4.88(2.61-17.23)
> 3.5	97	64.2
≤ 3.5	54	35.8
NSE† (ng/ml), median(IQR)	16.47(13.08-22.13)
> 16.3	72	50.7
≤ 16.3	70	49.3

^†N = 142.

NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; PAR, platelet-to-albumin ratio; Hb, hemoglobin; LDH, lactate dehydrogenase; CEA, carcinoembryonic antigen; NSE, neuron-specific enolase.